F6T Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Fate Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.8182 EUR Market Closed

Market Cap: €959.7m

F	Fate Therapeutics Inc XBER:F6T	US
	Candelaria Mining Corp OTC:CDELF	CA
C	CeoTronics Audio Video Data Communication AG XBER:CEK	DE
	LG H&H Co Ltd KRX:051905	KR
H	Henan Dayou Energy Co Ltd SSE:600403	CN
N	Nexans SA XMUN:NXS	FR
B	Bank of Kyoto Ltd F:BKY	JP
M	Mammoth Resources Corp OTC:MMMRF	CA
C	Carlo Gavazzi Holding AG F:D9N	CH
O	Olympus Corp DUS:OLY1	JP
	Elopak ASA F:9J7	NO
A	Ampol Ltd F:CLZ	AU
	LG H&H Co Ltd KRX:051900	KR
A	ANA Holdings Inc F:ANCA	JP
S	Steyr Motors AG XMUN:4X0	AT
	Northfield Capital Corp XTSX:JUN.A	CA

Profitability Summary

Fate Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-2 058%

Negative 3Y Average Operating Margin

-1 748%

Declining Operating Margin

-203% > -2 058%

Negative Net Margin

-1 941%

Negative 3Y Average Net Margin

-1 588%

Declining Net Margin

-177% > -1 941%

Negative Free Cash Flow Margin

-1 628%

Negative 3Y Average Free Cash Flow Margin

-1 215%

Declining Free Cash Flow Margin

-175% > -1 628%

Negative ROE

-61%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-106%

ROIC is Increasing

-113% > -108%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.